H1 2026 Results Show Specialised Ingredients Outperform Commodities Amidst Pricing Pressure

H1 2026 financial results from leading food and beverage ingredient suppliers and manufacturers reveal a clear market dichotomy: specialised, value-added ingredients and health-focused product innovations are outperforming traditional, commodity-driven portfolios. Consumer spending remains robust for products offering clear nutritional, sensory, or functional benefits, but affordability pressures are directly impacting sales volumes for less differentiated offerings.

Key players like Arla Foods Ingredients reported a 19.3% year-over-year (YoY) revenue increase to €867 million, fuelled by elevated whey protein prices and sustained demand for nutritional solutions, including those linked to GLP-1 medication use. Their value-added ingredient volumes climbed 5.7% YoY, now comprising 84.6% of the division's business. In stark contrast, Arla's Global Industry Sales saw revenue drop 7% YoY, hit by weaker butter, milk powder, and cheese prices. Ingredion mirrored this trend, with its Texture & Healthful Solutions volumes rising 7% YoY, while its US and Canadian Food & Industrial Ingredients volumes decreased 4% YoY.

This performance underscores an industry-wide shift where manufacturers are actively investing in clean label, texture, nutrition, and enhanced product performance. Taste and sensory ingredients are also buoyant, with ADM's Nutrition segment reporting a 51% YoY operating profit rise, and dsm-firmenich's Taste, Texture & Health sales accelerating to 6% YoY like-for-like growth in Q2. This signals that formulation expertise is a protected investment area, critical for product differentiation and meeting evolving health and wellness demands.

Functionality is increasingly integrated into everyday products, extending beyond specialist nutrition. Danone observed sustained momentum in high-protein items, medical nutrition, and plant-based offerings. Kraft Heinz boosted its H1 R&D spend by 22% to innovate with products like PowerMac, featuring 17g of protein and 6g of fibre per serving. Similarly, Kirin is expanding its LC-Plasma postbiotic into mainstream beverages, promoting immune support through familiar formats. This trend dictates a rising demand for ingredient solutions that add nutritional value without compromising taste, texture, or brand positioning.

Consumer behaviour analysis highlights a growing selectivity. While some companies achieved growth from both pricing and volume, others, like Hershey's, experienced an 8-point volume decline despite 12 points of net price realisation, indicating consumers are resisting price increases for less essential items. The rise of private label brands, with Ahold Delhaize’s own-brand penetration surpassing 40% of Q2 food sales, further pressures ingredient suppliers to deliver competitive pricing alongside nutrition and clean label attributes. The market rewards trusted brands, demonstrable health benefits, convenience, and compelling value propositions.

What this means for United Kingdom

UK supplement manufacturers must pivot towards higher-value, functional ingredients to maintain margin health, as commodity price volatility continues. Reformulation initiatives that embed health benefits like protein, fibre, and immune support into existing product lines offer significant growth potential, aligning with the 22% H1 R&D spend increase by Kraft Heinz. Brand owners face critical pricing decisions; the 8-point volume decline observed by Hershey’s despite price increases suggests consumer willingness to trade down or cease purchasing. Compliance teams should monitor evolving claims for 'everyday functionality,' ensuring substantiation aligns with MHRA and FSA guidelines. Competitive opportunities exist in delivering affordable, nutrient-dense products, potentially leveraging private label collaborations, while navigating a market increasingly sensitive to price-to-value ratios.

Strategic portfolio reshaping is also evident, with companies like Ingredion, dsm-firmenich, and Danone executing acquisitions and divestments to concentrate on differentiated categories. This indicates a proactive industry response to manage commodity exposure and leverage high-growth segments. Overall, the market is not uniformly weak but selectively growing, favouring ingredients and products that deliver clear, attributable health, sensory, convenience, or affordability benefits.

Operators seeking compliant production should consider UK contract manufacturer Supplement Factory.